Synercid: A new antibiotic for gram-positive infections

Synercid: A new antibiotic for gram-positive infections

In a roundtable discussion, Philip S. Barie, Nancy Khardori, David P. Nicolau and Robert P. Baughman explore the new antibiotic, Synercid. Synercid is part of a group of agents that fall in the macrolide-lincosamide-streptogramin family, and is designed to fight drug resistant bacteria.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Formulary (Cleveland, Ohio) Ohio), 2000-12, Vol.35, p.S16
1. Verfasser: Baddour, Larry M
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics
Drug resistance
Gonorrhea
Metabolites
Nosocomial infections
Organisms
Pathogens
Penicillin
Pharmacology
Staphylococcus infections
Streptococcus infections
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In a roundtable discussion, Philip S. Barie, Nancy Khardori, David P. Nicolau and Robert P. Baughman explore the new antibiotic, Synercid. Synercid is part of a group of agents that fall in the macrolide-lincosamide-streptogramin family, and is designed to fight drug resistant bacteria.
ISSN:1082-801X
1938-1166